Cheryl A. Grice

1.0k total citations
21 papers, 665 citations indexed

About

Cheryl A. Grice is a scholar working on Molecular Biology, Cancer Research and Physiology. According to data from OpenAlex, Cheryl A. Grice has authored 21 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Physiology. Recurrent topics in Cheryl A. Grice's work include Protease and Inhibitor Mechanisms (5 papers), Mast cells and histamine (4 papers) and Receptor Mechanisms and Signaling (3 papers). Cheryl A. Grice is often cited by papers focused on Protease and Inhibitor Mechanisms (5 papers), Mast cells and histamine (4 papers) and Receptor Mechanisms and Signaling (3 papers). Cheryl A. Grice collaborates with scholars based in United States. Cheryl A. Grice's co-authors include James P. Edwards, Lars Karlsson, Todd K. Jones, Robin L. Thurmond, Jianmei Wei, John J. M. Wiener, Nicholas I. Carruthers, Laurent Gomez, Paul J. Dunford and Wen Jiang and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and European Journal of Pharmacology.

In The Last Decade

Cheryl A. Grice

21 papers receiving 640 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl A. Grice United States 12 347 199 167 139 122 21 665
Lilia Weizel Germany 16 368 1.1× 229 1.2× 174 1.0× 41 0.3× 85 0.7× 34 704
Letizia Crocetti Italy 19 466 1.3× 185 0.9× 306 1.8× 59 0.4× 119 1.0× 63 866
Ritsuko Oka Japan 11 534 1.5× 181 0.9× 106 0.6× 381 2.7× 130 1.1× 17 781
Yoriko Takahashi Japan 13 350 1.0× 57 0.3× 65 0.4× 73 0.5× 27 0.2× 17 553
Émilie Sick France 13 333 1.0× 278 1.4× 16 0.1× 142 1.0× 29 0.2× 16 736
Inga Bauer Italy 15 396 1.1× 79 0.4× 39 0.2× 89 0.6× 73 0.6× 22 882
Yves Cambet Switzerland 9 184 0.5× 62 0.3× 89 0.5× 30 0.2× 26 0.2× 17 368
Yusuke Suzuki Japan 15 359 1.0× 60 0.3× 106 0.6× 48 0.3× 12 0.1× 25 543
Gareth Wayne United Kingdom 12 291 0.8× 32 0.2× 70 0.4× 182 1.3× 88 0.7× 13 605
Corinne E. Augelli‐Szafran United States 21 599 1.7× 45 0.2× 221 1.3× 144 1.0× 81 0.7× 62 1.1k

Countries citing papers authored by Cheryl A. Grice

Since Specialization
Citations

This map shows the geographic impact of Cheryl A. Grice's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl A. Grice with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl A. Grice more than expected).

Fields of papers citing papers by Cheryl A. Grice

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl A. Grice. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl A. Grice. The network helps show where Cheryl A. Grice may publish in the future.

Co-authorship network of co-authors of Cheryl A. Grice

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl A. Grice. A scholar is included among the top collaborators of Cheryl A. Grice based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl A. Grice. Cheryl A. Grice is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eckert, William A., John J. M. Wiener, Michael K. Ameriks, et al.. (2020). Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouse. European Journal of Pharmacology. 880. 173171–173171. 6 indexed citations
2.
Fraser, Iain D. C., Jacqueline L. Blankman, Jason R. Clapper, et al.. (2017). Preclinical characterization and first-in-human administration of a selective monoacylglycerol lipaseinhibitor, ABX-1431. Frontiers in Pharmacology. 8. 2 indexed citations
3.
Wiener, John J. M., Steven Nguyen, Siquan Sun, et al.. (2012). Pyrazole-based arylalkyne Cathepsin S inhibitors. Part III: Modification of P4 region. Bioorganic & Medicinal Chemistry Letters. 23(4). 1070–1074. 7 indexed citations
4.
Blevitt, Jonathan M., Christa C. Chrovian, Shelby Crawford, et al.. (2012). Azabenzthiazole inhibitors of leukotriene A4 hydrolase. Bioorganic & Medicinal Chemistry Letters. 22(24). 7504–7511. 12 indexed citations
5.
McClure, Kelly J., Michael P. Maher, Nancy Wu, et al.. (2011). Discovery of a novel series of selective HCN1 blockers. Bioorganic & Medicinal Chemistry Letters. 21(18). 5197–5201. 25 indexed citations
6.
Savall, Brad M., Laurent Gomez, Michael A. Curtis, et al.. (2011). Tricyclic aminopyrimidine histamine H4 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(21). 6577–6581. 19 indexed citations
7.
Wiener, John J. M., James P. Edwards, Lars Karlsson, et al.. (2010). Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: Modification of P3, P4, and P5 regions. Bioorganic & Medicinal Chemistry Letters. 20(7). 2375–2378. 11 indexed citations
8.
Bembenek, Scott D., Steven Nguyen, Robin L. Thurmond, et al.. (2010). Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(7). 2379–2382. 13 indexed citations
9.
Santillán, Alejandro, Kelly J. McClure, Brett D. Allison, et al.. (2010). Indole- and benzothiophene-based histamine H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(21). 6226–6230. 10 indexed citations
10.
Arienti, Kristen L., Jing Liu, Neelakandha S. Mani, et al.. (2010). Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: Part 1. Bioorganic & Medicinal Chemistry Letters. 20(7). 2370–2374. 7 indexed citations
11.
Wiener, John J. M. & Cheryl A. Grice. (2009). Practical Segregation of Incompatible Reagents in the Organic Chemistry Laboratory. Organic Process Research & Development. 13(6). 1395–1400. 1 indexed citations
12.
Grice, Cheryl A., Brad M. Savall, Jianmei Wei, et al.. (2008). Identification of a Potent, Selective, and Orally Active Leukotriene A4 Hydrolase Inhibitor with Anti-Inflammatory Activity. Journal of Medicinal Chemistry. 51(14). 4150–4169. 47 indexed citations
13.
Grice, Cheryl A. & Laurent Gomez. (2008). Current status of leukotriene A4hydrolase inhibitors. Expert Opinion on Therapeutic Patents. 18(12). 1333–1350. 2 indexed citations
14.
Rao, Navin, Paul J. Dunford, Xiaohua Xue, et al.. (2007). Anti-Inflammatory Activity of a Potent, Selective Leukotriene A4 Hydrolase Inhibitor in Comparison with the 5-Lipoxygenase Inhibitor Zileuton. Journal of Pharmacology and Experimental Therapeutics. 321(3). 1154–1160. 78 indexed citations
15.
Gomez, Laurent, Michael D. Hack, Jiejun Wu, et al.. (2007). Novel pyrazole derivatives as potent inhibitors of type II topoisomerases. Part 1: Synthesis and preliminary SAR analysis. Bioorganic & Medicinal Chemistry Letters. 17(10). 2723–2727. 73 indexed citations
16.
Wiener, John J. M., Laurent Gomez, Hariharan Venkatesan, et al.. (2007). Tetrahydroindazole inhibitors of bacterial type II topoisomerases. Part 2: SAR development and potency against multidrug-resistant strains. Bioorganic & Medicinal Chemistry Letters. 17(10). 2718–2722. 50 indexed citations
17.
Grice, Cheryl A., Haripada Khatuya, Darin J. Gustin, et al.. (2006). The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(8). 2209–2212. 10 indexed citations
18.
Jablonowski, Jill A., Cheryl A. Grice, Wenying Chai, et al.. (2003). The First Potent and Selective Non-Imidazole Human Histamine H4Receptor Antagonists. Journal of Medicinal Chemistry. 46(19). 3957–3960. 176 indexed citations
19.
Anthes, John C., Nicholas I. Carruthers, Cheryl A. Grice, et al.. (2002). Synthesis and structure–activity relationships of oxime neurokinin antagonists: discovery of potent arylamides. Bioorganic & Medicinal Chemistry Letters. 12(2). 141–145. 12 indexed citations
20.
Reichard, Gregory A., Cheryl A. Grice, Neng‐Yang Shih, et al.. (2002). Preparation of oxime dual NK1/NK2 antagonists with reduced NK3 affinity. Bioorganic & Medicinal Chemistry Letters. 12(17). 2355–2358. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lilia Weizel Breakdown of academic impact, for papers by Letizia Crocetti Breakdown of academic impact, for papers by Ritsuko Oka Breakdown of academic impact, for papers by Yoriko Takahashi Breakdown of academic impact, for papers by Émilie Sick Breakdown of academic impact, for papers by Inga Bauer Breakdown of academic impact, for papers by Yves Cambet Breakdown of academic impact, for papers by Yusuke Suzuki Breakdown of academic impact, for papers by Gareth Wayne Breakdown of academic impact, for papers by Corinne E. Augelli‐Szafran
Rankless by CCL
2026